GANX
Gain Therapeutics, Inc. [GANX] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GANX Stock Summary
Top 10 Correlated Stocks
GANX
In the News
GANX Financial details
Company Rating
-
Market Cap
0
Income
-22.27M
Revenue
55.18K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-2.13
Forward P/E
-
PEG
-1.37
P/S
390.7
P/B
6.46
P/C
-
P/FCF
-4.45
Quick Ratio
2.14
Current Ratio
2.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.71
EPS next Y
-
EPS next Q
-
EPS this Y
15.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
56.87%
Revenue last 5Y
5.97%
Revenue Q/Q
-
EPS Q/Q
-21.62%
-
-
-
-
SMA20
-
SMA50
-
SMA100
100%
Inst Own
-
Inst Trans
-
ROA
-158%
ROE
-169%
ROC
-2.69%
Gross Margin
100%
Oper. Margin
-11474%
Profit Margin
-11377%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
-
52W High
-
52W Low
-
RSI
56
Rel Volume
-
Avg Volume
-
Volume
78.35K
Perf Week
11.73%
Perf Month
48.97%
Perf Quarter
107.5%
Perf Half Y
137.43%
-
-
-
-
Beta
-
-
-
Volatility
0.07%, 0.23%
Prev Close
5.16%
Price
2.324
Change
5.64%